Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
18F-FDOPA Accumulation in Traumatic Rib Fractures: A Potential Pitfall
Published in: Clinical Nuclear Medicine
Access to document
10.1097/RLU.0000000000000761
F-FDOPA (6-[F]fluoro-L-DOPA) is used for the detection and staging of neuroendocrine tumors by visualizing the uptake of amine precursors in these tumors with high sensitivity and specificity. However, as this tracer is only available in a limited number of centers worldwide and the minority of the nuclear medicine specialists and referring clinicians is familiar with the distribution pattern of F-FDOPA, some physiological uptake patterns and pitfalls remain to be fully elucidated. Here, we present 2 cases of markedly increased uptake in the ribs after traumatic injury.
Gilles N. Stormezand, Andor W. J. M. Glaudemans, Riemer H. J. A. Slart
Challenges in diagnosing infection in the diabetic foot
Published in: Diabetic Medicine
Access to document
10.1111/dme.12750
Diagnosing the presence of infection in the foot of a patient with diabetes can sometimes be a difficult task. Because open wounds are always colonized with microorganisms, most agree that infection should be diagnosed by the presence of systemic or local signs of inflammation. Determining whether or not infection is present in bone can be especially difficult. Diagnosis begins with a history and physical examination in which both classic and secondary’ findings suggesting invasion of microorganisms or a host response are sought. Serological tests may be helpful, especially...
A. W. J. M. Glaudemans, I. Uckay, B. A. Lipsky
FES PET/CT analysis to evaluate the impact of localization of breast cancer metastases on ER expression.
Hilde H. Nienhuis, Michel van Kruchten, Andor W. J. M. Glaudemans, Alfons H. H. Bongaerts, Erik de Vries, Carolina Pia Schröder, Elisabeth G. E. de Vries, Geke Hospers
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
Published in: British Jounal of Cancer
Access to document
10.1038/bjc.2015.138
document
Background: The aim of this study was to evaluate the effect on the number of performed biopsies and costs associated with implementing positron emission tomography (PET) and computed tomography (PET/CT) with 16 alpha-[F-18]fluoro-17 beta-oestradiol (FES) or 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) as an upfront imaging test for diagnosing metastatic breast cancer (MBC) in comparison with the standard work-up in oestrogen receptor-positive women with symptoms. Methods: A published computer simulation model was adapted and validated. Three follow-up strategies were evaluated in a simulated cohort of women with primary breast cancer over...
R. G. Koleva-Kolarova, M. J. W. Greuter, M. van Kruchten, K. M. Vermeulen, T. Feenstra, E. Buskens, A. W. J. M. Glaudemans, E. F. J. de Vries, E. G. E. de Vries, G. A. P. Hospers, G. H. de Bock
IMPACT: op weg naar een gepersonaliseerde antikankerbehandeling met behulp van moleculaire beeldvorming. Drie lopende studies voor mamma-, colorectaal en niercelcarcinoom
E J van Helden, Suzanne van Es, Frederike Bensch, E Boon, C W Menke-van der Houven van Oordt, Carolina Schröder, C M L van Herpen, Adrienne Brouwers, Andor W.J.M. Glaudemans, O S Hoekstra, W.J.G. Oyen, W.T.A. van der Graaf, H M V Verheul, E. G. E. de Vries